Early and accurate detection of ovarian cancer by profiling cell-free…
A blood test measuring fragments of mitochondrial DNA can detect ovarian cancer early with high accuracy across diverse populations, potentially enabling earlier intervention.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Patient-specific genomic measurable residual disease markers for…
Custom genetic tests for individual leukemia patients enable doctors to track disease burden more sensitively than standard methods, helping predict treatment response.
Standard additionCNS targeted AAV gene therapies
Gene therapies using modified viruses show promise for rare brain and nervous system diseases, with emerging evidence guiding safer design and delivery.
Standard additionThe role of allogeneic hematopoietic stem cell transplantation in…
A rigorous review clarifies when stem cell transplantation may help adults with rare, aggressive T-cell lymphomas where treatment options are extremely limited.
Near-term implementable findingAI-Based Delirium Risk Prediction Compared With the Validated…
An AI tool using hospital records identifies which trauma patients will develop delirium 3 times more reliably than current bedside screening, allowing earlier preventive care.